Is AbbVie (ABBV) A Bargain After FDA Approval Of JUVMO For Parkinson's?
Is AbbVie (ABBV) A Bargain After FDA Approval Of JUVMO For Parkinson's? Yahoo Finance
Covered in this story
Call it yourself
No calls on $ABBV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on AbbVie →Dalsna Finance is currently tracking 52 stories mentioning AbbVie, the earliest published 19 Mar 2026.
Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.